Perspectives From Systems Biology to Improve Knowledge of Leishmania Drug Resistance
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Perspectives From Systems Biology to Improve Knowledge of Leishmania Drug Resistance
Authors
Keywords
-
Journal
Frontiers in Cellular and Infection Microbiology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-04-30
DOI
10.3389/fcimb.2021.653670
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mutations in an aquaglyceroporin as a proven marker of antimony clinical resistance in the parasite Leishmania donovani
- (2020) Jade-Eva Potvin et al. CLINICAL INFECTIOUS DISEASES
- The drug resistance mechanisms in Leishmania donovani are independent of immunosuppression
- (2020) Baibaswata Saha et al. CYTOKINE
- Unveiling six potent and highly selective antileishmanial agents via the open source compound collection ‘Pathogen Box’ against antimony-sensitive and -resistant Leishmania braziliensis
- (2020) Juliano A. Souza Silva et al. BIOMEDICINE & PHARMACOTHERAPY
- Comparative transcriptomic analysis of antimony resistant and susceptible Leishmania infantum lines
- (2020) Juvana Moreira Andrade et al. Parasites & Vectors
- An integrative approach using systems biology, mutational analysis with molecular dynamics simulation to challenge the functionality of a target protein
- (2019) Nikita Bora et al. Chemical Biology & Drug Design
- From biophysics to ‘omics and systems biology
- (2019) Marko Djordjevic et al. EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS
- Building protein-protein interaction networks for Leishmania species through protein structural information
- (2018) Crhisllane Rafaele dos Santos Vasconcelos et al. BMC BIOINFORMATICS
- Leishmaniasis treatment update of possibilities for drug repurposing
- (2018) Eduardo Caio Torres-Santos Frontiers in Bioscience-Landmark
- Transcription Factor Target Gene Network governs the Logical Abstraction Analysis of the Synthetic Circuit in Leishmaniasis
- (2018) Milsee Mol et al. Scientific Reports
- Ascorbate peroxidase overexpression protects Leishmania braziliensis against trivalent antimony effects
- (2018) Douglas de Souza Moreira et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- A systematic reconstruction and constraint-based analysis of Leishmania donovani metabolic network: identification of potential antileishmanial drug targets
- (2017) Mahesh Sharma et al. Molecular BioSystems
- Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India
- (2017) Saumya Srivastava et al. Parasites & Vectors
- Gene Expression in Leishmania Is Regulated Predominantly by Gene Dosage
- (2017) Stefano A. Iantorno et al. mBio
- HISP: a hybrid intelligent approach for identifying directed signaling pathways
- (2017) Xing-Ming Zhao et al. Journal of Molecular Cell Biology
- Leishmaniasis in humans: drug or vaccine therapy?
- (2017) Masoud Ghorbani et al. Drug Design Development and Therapy
- Drug resistance and treatment failure in leishmaniasis: A 21st century challenge
- (2017) Alicia Ponte-Sucre et al. PLoS Neglected Tropical Diseases
- Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: A systematic review
- (2017) Nayara Castelano Brito et al. PLoS One
- Molecular characterization and functional analysis of pteridine reductase in wild-type and antimony-resistant Leishmania lines
- (2016) Douglas de Souza Moreira et al. EXPERIMENTAL PARASITOLOGY
- Genomic and Molecular Characterization of Miltefosine Resistance in Leishmania infantum Strains with Either Natural or Acquired Resistance through Experimental Selection of Intracellular Amastigotes
- (2016) Annelies Mondelaers et al. PLoS One
- Functional analysis of iron superoxide dismutase-A in wild-type and antimony-resistant Leishmania braziliensis and Leishmania infantum lines
- (2015) N.G. Tessarollo et al. PARASITOLOGY INTERNATIONAL
- Phosphoproteomic analysis of wild-type and antimony-resistantLeishmania braziliensislines by 2D-DIGE technology
- (2015) Douglas de Souza Moreira et al. PROTEOMICS
- Arsenic Exposure and Outcomes of Antimonial Treatment in Visceral Leishmaniasis Patients in Bihar, India: A Retrospective Cohort Study
- (2015) Meghan R. Perry et al. PLoS Neglected Tropical Diseases
- Elucidation of Cellular Mechanisms Involved in Experimental Paromomycin Resistance in Leishmania donovani
- (2014) V. Bhandari et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Functional analysis of cytosolic tryparedoxin peroxidase in antimony-resistant and –susceptible Leishmania braziliensis and Leishmania infantum lines
- (2014) Juvana M Andrade et al. Parasites & Vectors
- The Genome Sequence of Leishmania (Leishmania) amazonensis: Functional Annotation and Extended Analysis of Gene Models
- (2013) F. Real et al. DNA RESEARCH
- Comparative proteomic analysis of antimony-resistant and -susceptible Leishmania braziliensis and Leishmania infantum chagasi lines
- (2013) Fabiana S.V. Matrangolo et al. MOLECULAR AND BIOCHEMICAL PARASITOLOGY
- Proteomic and Genomic Analyses of Antimony Resistant Leishmania infantum Mutant
- (2013) Marie-Christine Brotherton et al. PLoS One
- In vitro Antileishmanial Drug Susceptibility of Clinical Isolates from Patients with Indian Visceral Leishmaniasis—Status of Newly Introduced Drugs
- (2012) Vijay Kumar Prajapati et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- The Schistosoma mansoni phylome: using evolutionary genomics to gain insight into a parasite’s biology
- (2012) Larissa Silva et al. BMC GENOMICS
- Liposomal amphotericin B as a treatment for human leishmaniasis
- (2012) Manica Balasegaram et al. EXPERT OPINION ON EMERGING DRUGS
- Greater binding affinity of trivalent antimony to a CCCH zinc finger domain compared to a CCHC domain of kinetoplastid proteins
- (2012) Frédéric Frézard et al. Metallomics
- Computational Prediction of Protein-Protein Interactions in Leishmania Predicted Proteomes
- (2012) Antonio M. Rezende et al. PLoS One
- Mechanism of Amphotericin B Resistance in Clinical Isolates of Leishmania donovani
- (2011) Bidyut Purkait et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Differential expression of proteins in antimony-susceptible and -resistant isolates of Leishmania donovani
- (2011) Neha Biyani et al. MOLECULAR AND BIOCHEMICAL PARASITOLOGY
- Proteome mapping of overexpressed membrane-enriched and cytosolic proteins in sodium antimony gluconate (SAG) resistant clinical isolate of Leishmania donovani
- (2010) Awanish Kumar et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Taking a Systems Approach to the Identification of Novel Therapeutic Targets and Biomarkers
- (2010) David A. Dunn et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India
- (2010) S. Mandal et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Geographical Variation in the Response of Visceral Leishmaniasis to Paromomycin in East Africa: A Multicentre, Open-Label, Randomized Trial
- (2010) Asrat Hailu et al. PLoS Neglected Tropical Diseases
- What is systems biology?
- (2010) Rainer Breitling Frontiers in Physiology
- Philosophical Basis and Some Historical Aspects of Systems Biology: From Hegel to Noble - Applications for Bioenergetic Research
- (2009) Valdur Saks et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Drug Resistance in Visceral Leishmaniasis
- (2009) Helena C. Maltezou JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Roles of Trypanothione S-Transferase and Tryparedoxin Peroxidase in Resistance to Antimonials
- (2008) S. Wyllie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evolutionary conservation of RNA editing in the genus Leishmania
- (2008) Muntaser E. Ibrahim et al. INFECTION GENETICS AND EVOLUTION
- Systems analysis of metabolism in the pathogenic trypanosomatid Leishmania major
- (2008) Arvind K Chavali et al. Molecular Systems Biology
- Leishmania: conserved evolution – diverse diseases
- (2008) Miriam A. Lynn et al. TRENDS IN PARASITOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search